Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    crenezumab
Show Display Options
Rank Status Study
1 Completed A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose
Condition: Healthy Volunteer
Intervention: Drug: Crenezumab
2 Recruiting A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
3 Recruiting CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
4 Active, not recruiting A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease (AD), Including a Placebo-Treated Noncarrier Cohort
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
5 Active, not recruiting A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
Condition: Alzheimer's Disease
Intervention: Drug: Crenezumab
6 Active, not recruiting A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Drug: Crenezumab dose level 1;   Drug: Crenezumab dose level 2;   Drug: Crenezumb dose level 3;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.